Related Experiment Video
Updated: Jul 3, 2026
05:10
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Late recurrence of medulloblastoma
Brittney Stevens1, Faisal Razzaqi, Lolie Yu
1Tulane University, New Orleans, Louisiana, USA.
Summary
Late recurrence of cerebellar medulloblastoma can occur over 10 years after initial treatment. This case highlights the need for extended patient follow-up to detect rare, delayed medulloblastoma relapses.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Cancer Research
Background:
- Medulloblastoma is a common malignant brain tumor in children.
- Standard treatment includes surgery, radiation, and chemotherapy.
- Recurrence typically occurs within the first decade after diagnosis.
Observation:
- A three-year-old child diagnosed with cerebellar medulloblastoma experienced a recurrence 13 years post-initial treatment.
- This late recurrence surpassed established 10-year survival benchmarks and the Collins rule.
Findings:
- The case demonstrates that medulloblastoma can recur significantly later than commonly predicted.
- Late recurrences challenge current follow-up protocols based on shorter observation periods.
Implications:
- Extended long-term surveillance for pediatric medulloblastoma survivors is warranted.
- Further research into the mechanisms and patterns of late medulloblastoma recurrence is needed.
